Stephen S. Arnon

3.8k total citations
46 papers, 2.2k citations indexed

About

Stephen S. Arnon is a scholar working on Neurology, Public Health, Environmental and Occupational Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Stephen S. Arnon has authored 46 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Neurology, 16 papers in Public Health, Environmental and Occupational Health and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Stephen S. Arnon's work include Botulinum Toxin and Related Neurological Disorders (38 papers), Neurological disorders and treatments (20 papers) and Streptococcal Infections and Treatments (16 papers). Stephen S. Arnon is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (38 papers), Neurological disorders and treatments (20 papers) and Streptococcal Infections and Treatments (16 papers). Stephen S. Arnon collaborates with scholars based in United States, Finland and Ireland. Stephen S. Arnon's co-authors include Jason R. Barash, James Chin, Karla Damus, Nicholas P. Jewell, Robert Schechter, Nir Dover, C L Hatheway, Susan E. Maslanka, Karen K. Hill and T. F. Midura and has published in prestigious journals such as New England Journal of Medicine, JAMA and PLoS ONE.

In The Last Decade

Stephen S. Arnon

45 papers receiving 2.1k citations

Peers

Countries citing papers authored by Stephen S. Arnon

Since Specialization

Citations

This map shows the geographic impact of Stephen S. Arnon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen S. Arnon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen S. Arnon more than expected).

Fields of papers citing papers by Stephen S. Arnon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen S. Arnon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen S. Arnon. The network helps show where Stephen S. Arnon may publish in the future.

Co-authorship network of co-authors of Stephen S. Arnon

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen S. Arnon. A scholar is included among the top collaborators of Stephen S. Arnon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen S. Arnon. Stephen S. Arnon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dual-Toxin (“Bivalent”) Infant Botulism in California, 1976-2020: Epidemiologic, Clinical, and Laboratory Aspects 2022 ·The Journal of Pediatrics ·(unknown), (unknown), (unknown), Jason R. Barash, Ruth Motter, Nir Dover, Stephen S. Arnon	3
2	Seven-Year Case-Control Study in California of Risk Factors for Infant Botulism 2020 ·The Journal of Pediatrics ·(unknown), Haydee A. Dabritz, (unknown), Karla Damus, (unknown), Stephen S. Arnon	13
3	Descriptive Epidemiology of Infant Botulism in California: The First 40 Years 2020 ·The Journal of Pediatrics ·(unknown), Haydee A. Dabritz, (unknown), Karla Damus, (unknown), Stephen S. Arnon	16
4	Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity 2018 ·Vaccine ·(unknown), Ruth Motter, Stephen S. Arnon	26
5	Efficacy of Human Botulism Immune Globulin for the Treatment of Infant Botulism: The First 12 Years Post Licensure 2017 ·The Journal of Pediatrics ·(unknown), (unknown), Nicholas P. Jewell, Stephen S. Arnon	30
6	More Clinical Mimics of Infant Botulism 2017 ·The Journal of Pediatrics ·(unknown), (unknown), Stephen S. Arnon	14
7	Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H 2016 ·The Journal of Infectious Diseases ·Yongfeng Fan, Jason R. Barash, Jianlong Lou, Fraser Conrad, James D. Marks, Stephen S. Arnon	31
8	Molecular Epidemiology of Infant Botulism in California and Elsewhere, 1976–2010 2014 ·The Journal of Infectious Diseases ·Haydee A. Dabritz, Karen K. Hill, Jason R. Barash, Lawrence O. Ticknor, (unknown), Nir Dover, (unknown), Stephen S. Arnon	29
9	Clostridium botulinum Strain Af84 Contains Three Neurotoxin Gene Clusters: Bont/A2, bont/F4 and bont/F5 2013 ·PLoS ONE ·Nir Dover, Jason R. Barash, Karen K. Hill, Karen W. Davenport, Hazuki Teshima, Gary Xie, Stephen S. Arnon	34
10	Molecular Characterization of a Novel Botulinum Neurotoxin Type H Gene 2013 ·The Journal of Infectious Diseases ·Nir Dover, Jason R. Barash, Karen K. Hill, Gary Xie, Stephen S. Arnon	186
11	A Novel Strain of Clostridium botulinum That Produces Type B and Type H Botulinum Toxins 2013 ·The Journal of Infectious Diseases ·Jason R. Barash, Stephen S. Arnon	222
12	Universal and specific quantitative detection of botulinum neurotoxin genes 2010 ·BMC Microbiology ·Brenna J. Hill, (unknown), Theresa J. Smith, Stephen S. Arnon, Daniel C. Douek	28
13	Presence of Soil-Dwelling Clostridia in Commercial Powdered Infant Formulas 2009 ·The Journal of Pediatrics ·Jason R. Barash, Jennifer K. Hsia, Stephen S. Arnon	31
14	Attomolar Detection of Botulinum Toxin Type A in Complex Biological Matrices 2008 ·PLoS ONE ·Karine Bagramyan, Jason R. Barash, Stephen S. Arnon, Markus Kalkum	87
15	Human Botulism Immune Globulin for the Treatment of Infant Botulism 2006 ·New England Journal of Medicine ·Stephen S. Arnon, Robert Schechter, Susan E. Maslanka, Nicholas P. Jewell, C L Hatheway	254
16	Botulinum toxin as a biological weapon 2001 ·JAMA ·Stephen S. Arnon, Robert Schechter, Thomas V. Inglesby, Donald A. Henderson, John G. Bartlett, Michael S. Ascher, Edward M. Eitzen, Anne D. Fine, Jerome Hauer, Marcelle Layton, Scott R. Lillibridge, Michael T. Osterholm, Tara O’Toole, Gerald Parker, Trish M. Perl, Philip K. Russell, David L. Swerdlow, Kevin Tonat	95
17	Inhibition of Growth ofClostridium botulinumby Intestinal Microflora Isolated from Healthy Infants 1988 ·Microbial Ecology in Health and Disease ·Nadine M. Sullivan, Daniel C. Mills, H. P. Riemann, Stephen S. Arnon	17
18	Infant Botulism: Anticipating the Second Decade 1986 ·The Journal of Infectious Diseases ·Stephen S. Arnon	39
19	Rapid death of infant rhesus monkeys injected with Clostridium difficile toxins A and B: Physiologic and pathologic basis 1984 ·The Journal of Pediatrics ·Stephen S. Arnon, Daniel C. Mills, (unknown), Roy V. Henrickson, Nadine M. Sullivan, Tracy D. Wilkins	45
20	Protective role of human milk against sudden death from infant botulism 1982 ·The Journal of Pediatrics ·Stephen S. Arnon, Karla Damus, Barbara Thompson, T. F. Midura, James Chin	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact